Wells Fargo & Company »

Tempest Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $421 96 4.40
2023-09-30 $14 49 0.31
2023-06-30 $98 78 1.27
2022-12-31 $78 68 1.15
2022-09-30 $0 65 0.00
2022-06-30 $0 39 0.00
2022-03-31 $0 35 0.00
2021-12-31 $0 35 0.00
2021-09-30 $0 33 0.00
2021-06-30 $0 8 0.00